(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EVOSCRIPT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EVOSCRIPT

ST13

US500000086760960

Class

1, 5

Filing

86760960

Registration

5125375

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

05/19/2026

Trademark type

Word

Nice classes

1, 5

Filing date

09/18/2015

Registration date

01/17/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/24/2026

Last transaction

05/19/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/14/2016

First use in commerce

10/14/2016

Drawing code

4

Owner type

03

Owner location

Pleasanton, CA, US

Examiner

LEE, DOUGLAS

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Roche Molecular Systems, Inc.

Representatives

Mona Gupta Roche Diagnostics Operations, Inc.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical reagents for use in clinical and medical research laboratories for scientific and research purposes; polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR) reagents for scientific and medical research purposes; reagents for gene expression quantification for scientific and medical research purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; biological enzymes used for clinical or medical laboratory use

Class 5

Complementary DNA (cDNA) synthesizing kits for medical purposes consisting of chemical reagents for cDNA synthesis for medical purposes

Publications

History of USPTO decisions and trademark events.

52 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/24/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/24/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/24/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/23/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

02/17/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/17/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/10/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/10/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/10/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/17/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/17/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/17/2022

E815

TEAS SECTION 8 & 15 RECEIVED

05/12/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/17/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/19/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/19/2020

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

10/19/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/19/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/19/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/19/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/27/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/27/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/02/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/02/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/09/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/09/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

01/17/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/16/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/15/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/15/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/15/2016

IUAF

USE AMENDMENT FILED

11/28/2016

EISU

TEAS STATEMENT OF USE RECEIVED

11/28/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/24/2016

EX1G

SOU EXTENSION 1 GRANTED

11/22/2016

EXT1

SOU EXTENSION 1 FILED

11/22/2016

EEXT

SOU TEAS EXTENSION RECEIVED

11/22/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/31/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/05/2016

PUBO

PUBLISHED FOR OPPOSITION

04/05/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/16/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/29/2016

ALIE

ASSIGNED TO LIE

02/23/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/22/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

01/13/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/13/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

01/13/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/13/2016

DOCK

ASSIGNED TO EXAMINER

01/06/2016

MPMK

NOTICE OF PSEUDO MARK E-MAILED

09/23/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/22/2015

NWAP

NEW APPLICATION ENTERED

09/22/2015

Continuous trademark protection

Get notified about every new filing that threatens EVOSCRIPT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.